Aerie Pharmaceuticals reported $45.53M in Net Income for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aerie Pharmaceuticals AERI:US $ 45.53M 85.22M
Alimera Sciences ALIM:US $ -4.11M 0.08M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Novartis NOVN:VX SF 16308M 13550M
Ophthotech OPHT:US $ -34.54M 1.5M
Valeant Pharmaceuticals VRX:CN $ 69M 119M
Zoetis ZTS:US $ 414M 138M